Caricamento...
Metabolic actions of the type 1 cholecystokinin receptor: its potential as a therapeutic target
Cholecystokinin regulates appetite and reduces food intake by activating the type 1 CCK receptor (CCK1R). Attempts to develop CCK1R agonists for obesity have yielded active agents that have not reached clinical practice. In this review we discuss why, along with new strategies to target CCK1R more e...
Salvato in:
| Pubblicato in: | Trends Endocrinol Metab |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4992613/ https://ncbi.nlm.nih.gov/pubmed/27156041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tem.2016.04.002 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|